Yi Ba

843 total citations
23 papers, 665 citations indexed

About

Yi Ba is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yi Ba has authored 23 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Yi Ba's work include MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yi Ba is often cited by papers focused on MicroRNA in disease regulation (8 papers), Extracellular vesicles in disease (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yi Ba collaborates with scholars based in China, United States and Netherlands. Yi Ba's co-authors include Haiyang Zhang, Ting Deng, Guoguang Ying, Xinyi Wang, He Zhou, Rong Xiang, Juergen C. Becker, Noriko Mizutani, Haiou Yang and Claudia Chiodoni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Yi Ba

20 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Ba China 11 503 322 119 98 75 23 665
Keun Koo Shin South Korea 12 304 0.6× 199 0.6× 52 0.4× 44 0.4× 73 1.0× 12 544
Carla Riera‐Domingo Belgium 5 263 0.5× 257 0.8× 325 2.7× 146 1.5× 22 0.3× 6 662
Myung Won Seo South Korea 10 201 0.4× 106 0.3× 194 1.6× 175 1.8× 33 0.4× 13 526
Audrey Champagne Canada 9 321 0.6× 148 0.5× 150 1.3× 224 2.3× 26 0.3× 14 616
George Koutsodontis Greece 12 356 0.7× 201 0.6× 70 0.6× 402 4.1× 24 0.3× 20 674
Buqing Sai China 11 524 1.0× 402 1.2× 101 0.8× 168 1.7× 13 0.2× 23 746
Liangsheng Fan China 17 325 0.6× 163 0.5× 133 1.1× 232 2.4× 17 0.2× 29 591
Magdalena Potoczek United States 11 321 0.6× 161 0.5× 60 0.5× 162 1.7× 26 0.3× 16 589
Leili Saeednejad Zanjani Iran 13 273 0.5× 114 0.4× 74 0.6× 201 2.1× 24 0.3× 37 497
Adilson Fonseca Teixeira Australia 7 294 0.6× 161 0.5× 107 0.9× 166 1.7× 20 0.3× 17 486

Countries citing papers authored by Yi Ba

Since Specialization
Citations

This map shows the geographic impact of Yi Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ba more than expected).

Fields of papers citing papers by Yi Ba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ba. The network helps show where Yi Ba may publish in the future.

Co-authorship network of co-authors of Yi Ba

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Ba. A scholar is included among the top collaborators of Yi Ba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Ba. Yi Ba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ba, Yi, et al.. (2025). Investigation of texture evolution and multi-mechanism strengthening in NiTi alloy produced via selective laser melting. Journal of Materials Research and Technology. 39. 1960–1976.
2.
Ba, Yi, et al.. (2025). Cu-enhanced NiTi alloys: Microstructure, phase transformation, and mechanical performance. Materials Today Communications. 49. 113897–113897.
3.
Wang, Weixue, et al.. (2024). Feasibility and Safety of PD-1 Blockades Among Elderly Patients with Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Study. Drug Design Development and Therapy. Volume 18. 4135–4151. 1 indexed citations
4.
Zhang, Kailun, Hongxia Xu, Wei Li, et al.. (2024). Investigation on quality of life of hospitalized patients in China with digestive system malignancy. 9(2). 53–62. 2 indexed citations
5.
Ba, Yi, et al.. (2024). Effect of Energy Density on Mechanical Properties of NiTiCu Shape Memory Alloys Prepared by SLM. Materials. 17(23). 5693–5693. 6 indexed citations
6.
Li, Shuang, Jialu Li, Haiyang Zhang, et al.. (2021). Gastric cancer derived exosomes mediate the delivery of circRNA to promote angiogenesis by targeting miR-29a/VEGF axis in endothelial cells. Biochemical and Biophysical Research Communications. 560. 37–44. 51 indexed citations
7.
Zhang, Haiyang, Zhengyang Zhou, Rui Liu, et al.. (2021). Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer. International Journal of General Medicine. Volume 14. 1185–1195. 10 indexed citations
8.
Lin, Dan, Haiyang Zhang, Rui Liu, et al.. (2021). iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Molecular Oncology. 15(12). 3430–3446. 86 indexed citations
9.
D, Liu, Rong Liu, Ming Bai, et al.. (2020). Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
10.
Ge, Shaohua, Haiyang Zhang, Ting Deng, et al.. (2019). MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer. Investigational New Drugs. 37(5). 923–934. 12 indexed citations
11.
Song, Chunhua, Jingjing Cao, Feng Zhang, et al.. (2019). Nutritional Risk Assessment by Scored Patient-Generated Subjective Global Assessment Associated with Demographic Characteristics in 23,904 Common Malignant Tumors Patients. Nutrition and Cancer. 71(1). 50–60. 46 indexed citations
12.
Wang, Xinyi, Haiyang Zhang, Haiou Yang, et al.. (2018). Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy. Current Cancer Drug Targets. 18(4). 347–354. 45 indexed citations
13.
Wang, Jingya, Yue Zhang, Shaohua Ge, et al.. (2018). Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts. Cellular Physiology and Biochemistry. 49(3). 869–883. 103 indexed citations
14.
Duan, Jingjing, Haiyang Zhang, Shuang Li, et al.. (2017). The role of miR-485-5p/NUDT1 axis in gastric cancer. Cancer Cell International. 17(1). 92–92. 34 indexed citations
15.
Ba, Yi, Christine L. Mummery, & Kenneth R. Chien. (2013). Direct Cardiomyocyte Reprogramming: A New Direction for Cardiovascular Regenerative Medicine. Cold Spring Harbor Perspectives in Medicine. 3(9). a014050–a014050. 15 indexed citations
16.
Ba, Yi, et al.. (2011). A meta-analysis of ginsenoside Rg3 for non-small cell lung cancer. Clinical Oncology and Cancer Research. 8(3). 175–180. 4 indexed citations
17.
Ba, Yi, Xing Fu Cai, Xi Chen, et al.. (2008). [Down-regulative expression of microRNAs cluster in human colon tumorigenesis].. PubMed. 88(24). 1683–6. 1 indexed citations
18.
Zhang, Yan, Yi Ba, Chang Liu, et al.. (2007). PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway. Cell Research. 17(4). 363–373. 87 indexed citations
19.
Xiang, Rong, Noriko Mizutani, Yunping Luo, et al.. (2005). A DNA Vaccine Targeting Survivin Combines Apoptosis with Suppression of Angiogenesis in Lung Tumor Eradication. Cancer Research. 65(2). 553–561. 132 indexed citations
20.
Ruehlmann, J M, Andreas G. Niethammer, Yi Ba, et al.. (2001). MIG(CXCL9)ケモカイン遺伝子療法と抗体-サイトカイン融合蛋白質の併用はマウス結腸癌の増殖と播種を抑制する. Cancer Research. 61(23). 8498–8503. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026